(Q35162221)

English

Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Peter Widdess-Walsh

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jinny O Tavee

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Stephan Schuele

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Glen H Stevens

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

187-190

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12825823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1023931501503

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35162221&oldid=2197305054"